Michael Patrick Miller - Jun 26, 2023 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
Director
Signature
/s/ Richard I. Steinhart, Attorney-in-Fact for Michael Miller
Stock symbol
BTAI
Transactions as of
Jun 26, 2023
Transactions value $
$0
Form type
4
Date filed
6/28/2023, 04:59 PM
Previous filing
Jun 15, 2023
Next filing
Nov 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Stock Option (Right to Buy) Award $0 +17K $0.00 17K Jun 26, 2023 Common Stock 17K $17.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.